GSK plc ( GLAXF) - Stock Earnings
GLAXF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 28, 2026, midnight | — / — | — | — / — | — |
GLAXF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 854.5 million USD | 11.6 billion USD |
| 2026Q1 | 2.3 billion USD | 10.1 billion USD |
| 2026Q2 | 572.1 million USD | 11.1 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GLAXF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.3 billion USD | 38.6 billion USD |
| 2024 | 3.2 billion USD | 39.4 billion USD |
| 2025 | 7.7 billion USD | 43.9 billion USD |
| 2026 Est. | — | — |
GLAXF
Price: $23.55
Dividend Yield: 3.61%
Payout Ratio: 51.48%
Earnings Per Share: 1.57 USD
P/E Ratio: 16.38
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Market Capitalization: 101.0 billion
Average Dividend Frequency: 8
Years Paying Dividends: 23
DGR3: 13.82%
DGR5: 6.76%
DGR10: 1.46%
DGR20: 6.10%